Download PDF
Endoscopy 1987; 19(5): 201-202
DOI: 10.1055/s-2007-1013018
© Georg Thieme Verlag KG Stuttgart · New York

A Randomised, Prospective Study Comparing Two Contrast Media in ERCP

W. J. Cunliffe1 , I. Cobden2 , M. I. Lavelle3 , R. Lendrum2 , N. P. Tait3 , C. W. Venables1
  • 1Department of Surgery, Freeman Hospital, Newcastle upon Tyne, U.K.
  • 2Department of Medicine, Freeman Hospital, Newcastle upon Tyne, U.K.
  • 3Department of Radiology, Freeman Hospital, Newcastle upon Tyne, U.K.
The contrast media used in this study was supplied by May and Baker Ltd., Dagenham, Essex
Further Information

Publication History

Publication Date:
17 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

See also:

Contrast Media for ERCPEndoscopy 1988; 20(03): 126-127
DOI: 10.1055/s-2007-1013024

Summary

A randomised, prospective, stratified, double blind study comparing two contrast media in endoscopic retrograde cholangio-pancreatography (ERCP) was undertaken. Forty-six patients received Meglumine/Sodium loxaglate (Hexabrix 320) and forty-eight received Meglumine/Sodium Diatrizoate (Urografin 310).

The two groups were evenly matched for age, sex and diagnosis. Radiographs were examined independently by two radiologists. There were no differences in radiograph quality with either type of contrast medium. More patients developed pancreatitis following Urografin, suggesting that Hexabrix is a safer contrast medium for ERCP.

Key words:

Contrast media - ERCP - Endoscopy - Radiography

      >